Horizon Technology Finance Third Quarter 2026 Earnings Call - HORIZON TECHNOLOGY FINANCE CORP

Explicit Guidance:

• Distributions: Declared monthly distributions of $0.06 per share for January, February, and March 2027, based on outlook and undistributed spillover income of $0.24 per share as of September 30, 2026.
• Net Investment Income (NII) Targets: Stated goal to deliver NII at or above declared distributions ($0.72 annualized) over time as capital is deployed and leverage targets are approached.
• Share Repurchases: Expect to remain opportunistic with the remaining balance of the $20 million stock repurchase program (2 million shares repurchased in Q3 at $4.90 average) given valuation dislocation.
• Leverage Targets: No specific target date provided, but net leverage (0.82x as of Q3) is noted as well below target, creating capacity for portfolio growth.
• Investment Volume: Expects "some decent conversion" on the pipeline within a rolling six-month horizon; fourth-quarter prepayment activity anticipated to be lower than Q3's elevated levels.

Business-Segment Outlook:

• Portfolio Growth: Pipeline and committed backlog increased to $351 million at Q3 end (up $42 million), positioned to "materially grow" the portfolio in Q4 2026 and beyond.
• Investment Yields: Onboarding yields expected to remain strong; Q3 onboarding yield was 12.6%, driven by a rising rate environment. Portfolio yield stood at 14.7%.
• Credit Quality: 88% of the debt portfolio fair value is rated 1-3 (investment grade/solid) under the new credit scale; 12% rated 4-5.
• Stressed Assets: Working diligently to stabilize and recover value from stressed credits (notably 4-5 rated), with management noting improvements should become "more apparent" as they move into 2027.
• Equity/Warrants: Continued strategy of structuring deals with warrants/equity rights; realized $4.3 million from equity/warrants in the last six months, expected to continue generating value.
• Backlog Composition: Majority of funding commitments are subject to portfolio companies achieving specific milestones.

Market and Competitive Outlook:

• Capital Environment: VC market remains "significantly bifurcated" with $98 billion invested in V-Feedback companies in Q3 (up 44% YTD), heavily concentrated in AI.
• Exit Market: IPO market expected to remain "quiet" for the remainder of 2026, except for a potential massive valuation exit for Anthropic later in the quarter.
• Originations: Significant opportunities anticipated to remain in venture debt for life sciences and tech despite top-heavy capital allocation in the broader VC market.
• Prepayments: Q3 saw elevated prepayments ($81 million); fourth-quarter prepayment activity anticipated to be lower due to the current macro environment.
• Competitive Position: Maintains industry-leading yields (top of BDC industry) through venture lending strategy, supported by a robust pipeline and ability to co-invest with Monroe Capital.

Macro / Industry Outlook:

• Interest Rates: "Rising rate environment" is cited as a contributor to higher onboarding yields (12.6% in Q3).
• Rate Sensitivity: 98% of the portfolio is floating-rate and will benefit from additional increases in applicable pricing indices.
• Geopolitical/Macro: Non-AI exit market activity remains muted due to "ongoing uncertainty in the macro and geopolitical environment."
• AI Sector: Market bifurcation observed where "certain companies at the very top [receive] the lion's share of capital," primarily AI-focused.

Strategic Initiatives:

• Leadership Expansion: Appointed Manuel Enriquez as the new Chief Growth and Strategy Officer to accelerate impact, leveraging his experience from Hercules to enhance origination and portfolio management.
• Platform Synergy: Executing on a strategic vision backed by Monroe Capital to create a "sustainable growth engine" that increases NII and NAV over time.
• Scale Optimization: Believes the platform is successfully laying the foundation for long-term portfolio growth and increasing NII.
• Investment Structure: Continuing to focus on high-quality companies in target sectors (life sciences, tech) with structured equity rights.

Risks and Headwinds to Outlook:

• Credit Pressures: NAV per share remains under stress due to write-downs of specific investments; management acknowledges "shortfalls" in expected outcomes for certain names.
• Recovery Uncertainty: Management declined to provide specific timelines for stabilizing stressed credits, citing sensitivity and uncertainty.
• Market Concentration: Heavy reliance on AI sector dynamics could impact broader deal flow if the bifurcation persists or worsens.
• Pipeline Fluidity: Deal timelines are described as "nuanced and idiosyncratic," with potential for delays or acceleration.
• Macro Sensitivity: Broader geopolitical and macro uncertainty continues to mute exit markets for non-AI companies, potentially impacting liquidity events.

Management Tone on the Future:

• Confidence: Expressed "strong confidence" in the near and long-term outlook, citing the "strongest" backlog in "quite a while."
• Optimism: Described as "extremely encouraged" by pipeline momentum and the strategic team; believes they are in an "excellent position" to grow the portfolio.
• Caveats: While optimistic, management acknowledges current NAV stress and the "unfortunate" nature of simultaneous credit shortfalls, framing 2027 as the period where headway on challenges will become "more apparent."
• Stance: Reaffirms commitment to delivering shareholder value and creating a sustainable growth engine despite current headwinds.

Miscellaneous:

• Liquidity: $211 million in available liquidity as of Q3 end ($108M cash + $103M borrowing capacity).
• Capacity: Potential new investment capacity estimated at $387 million as of September 30, 2026.
• Advisory Fees: Advisor agreed to waive up to $4 million aggregate (or $1M/quarter) of fees to offset expenses; $1M waived in Q3.